Lv6
2230 积分 2025-12-02 加入
Early intervention with secukinumab prevents epigenetic scar development in new-onset psoriasis: STEPIn mechanistic substudy results
12天前
已完结
Disease modification in psoriasis through early interleukin 17 inhibitor intervention: A retrospective cohort study
12天前
已完结
Impact of early treatment of psoriasis on disease recurrence—Results from the STEPIn study
12天前
已完结
A crossover study of triptorelin and leuprorelin acetate
25天前
已完结
Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
28天前
已完结
Evolution of the psoriasis therapy landscape
28天前
已完结
Bimekizumab versus Adalimumab in Plaque Psoriasis
1个月前
已完结
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
1个月前
已完结
Bimekizumab versus Secukinumab in Plaque Psoriasis
1个月前
已完结
Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
1个月前
已完结
皖公网安备34019202002308
